Dr. Maren Fragala, Director of Clinical Operations at HealthTrackRx, spearheads the evidence strategy for next-day, syndromic molecular testing for infectious diseases, showcasing its significant impact on prescribing behavior, follow-up care, and cost savings. Her career began in academia as a translational health researcher and expanded into the healthcare industry, where she has driven advancements in population health through research, implementation, and innovative solutions.
Dr. Fragala's professional accolades include earning the prestigious C. Everett Koop Award ‘Rising Star in Healthcare,’ ‘Top Woman in Wellness,’ and ‘Women We Admire’ Awards for her seminal contributions to health and disease prevention. She has played a pivotal role in the FNIH’s initiative to define sarcopenia, led the NSCA’s Position Statement for Older Adults, and contributed to the NSCA’s Position Statement for Women. Her extensive impact spans preventative health, human performance, infectious disease, diabetes, chronic kidney disease, pharmacogenomics, sarcopenia, cancer, metabolic diseases, and is showcased among 150 peer-reviewed manuscripts and over 150 research presentations.
Sponsored by Health Enhancement Research Organization (HERO), a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive Category I continuing education contact hours. Provider ID#101039
